Neovacs: BIO Europe (Neovacs) - Mar 27, 2015 - Anticipated data from P2b trial in lupus in EU, Asia and Latin America in Q1 2017; Anticipated data from P2a trial in lupus in US in Q3 2017; Anticipated initiation of P2a trial in dermatomyositis in adults in EU in Q4 2015; Anticipated data from P2a trial in dermatomyositis in adults in EU in Q1 2017; Anticipated initiation of P2b trial in dermatomyositis in adults in US, EU and Asia in Q2 2017; Anticipated data from P2b trial in dermatomyositis in adults in US, EU and Asia in Q1 2019; Anticipated initiation of P2a/b trial in pediatric dermatomyositis in US and EU in Q3 2016; Anticipated data from P2a/b trial in pediatric dermatomyositis in US and EU in Q3 2018
Anticipated new P2 trial • Anticipated new P2b trial • Anticipated P2a data • Anticipated P2b data • Immunology • Lupus
|